Cargando…

First report of OPA1 screening in Greek patients with autosomal dominant optic atrophy and identification of a previously undescribed OPA1 mutation

PURPOSE: To describe the genotype–phenotype correlation in four Greek pedigrees with autosomal dominant optic atrophy (ADOA) and OPA1 mutations. METHODS: Seven patients from four unrelated families (F1, F2, F3, F4) were clinically assessed for visual acuity, color vision, ptosis, afferent pupillary...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamakari, Smaragda, Koutsodontis, George, Tsilimbaris, Miltiadis, Fitsios, Athanasios, Chrousos, Georgia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Vision 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037535/
https://www.ncbi.nlm.nih.gov/pubmed/24883014
_version_ 1782318246762905600
author Kamakari, Smaragda
Koutsodontis, George
Tsilimbaris, Miltiadis
Fitsios, Athanasios
Chrousos, Georgia
author_facet Kamakari, Smaragda
Koutsodontis, George
Tsilimbaris, Miltiadis
Fitsios, Athanasios
Chrousos, Georgia
author_sort Kamakari, Smaragda
collection PubMed
description PURPOSE: To describe the genotype–phenotype correlation in four Greek pedigrees with autosomal dominant optic atrophy (ADOA) and OPA1 mutations. METHODS: Seven patients from four unrelated families (F1, F2, F3, F4) were clinically assessed for visual acuity, color vision, ptosis, afferent pupillary defects, and visual fields and underwent orthoptic assessment, slit-lamp biomicroscopy, and fundus examination to establish their clinical status. Genomic DNA was extracted from peripheral blood samples from all participants. The coding region (exons 1–28), including the intron-exon boundaries of the OPA1 gene, was screened in the probands of the four families, as well as in seven additional family members (four affected and three unaffected) with PCR and direct DNA sequencing. RESULTS: All patients presented bilateral decrease in best-corrected visual acuity and temporal pallor of the optic disc. The visual fields of the adult patients showed characteristic scotomata. Other signs were present in some patients such as decreased color discrimination and a gray crescent within the neuroretinal rim. After the OPA1 gene was sequenced, a previously undescribed heterozygous splice-site mutation c.784–1G>T in intron 7 was detected in family F2. In families F1, F3, and F4, a previously reported in-frame deletion c.876_878delTGT/p.(Val294del), the frameshift c.2366delA/p.(Asn789Metfs*11), and splice-site c.1140+5G>C mutations were detected, respectively. CONCLUSIONS: This is the first report of molecular characterization of Greek patients with ADOA. Our findings provide additional information regarding the genotype-phenotype correlation and establish the role of the OPA1 gene in Greek patients with ADOA.
format Online
Article
Text
id pubmed-4037535
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Molecular Vision
record_format MEDLINE/PubMed
spelling pubmed-40375352014-05-30 First report of OPA1 screening in Greek patients with autosomal dominant optic atrophy and identification of a previously undescribed OPA1 mutation Kamakari, Smaragda Koutsodontis, George Tsilimbaris, Miltiadis Fitsios, Athanasios Chrousos, Georgia Mol Vis Research Article PURPOSE: To describe the genotype–phenotype correlation in four Greek pedigrees with autosomal dominant optic atrophy (ADOA) and OPA1 mutations. METHODS: Seven patients from four unrelated families (F1, F2, F3, F4) were clinically assessed for visual acuity, color vision, ptosis, afferent pupillary defects, and visual fields and underwent orthoptic assessment, slit-lamp biomicroscopy, and fundus examination to establish their clinical status. Genomic DNA was extracted from peripheral blood samples from all participants. The coding region (exons 1–28), including the intron-exon boundaries of the OPA1 gene, was screened in the probands of the four families, as well as in seven additional family members (four affected and three unaffected) with PCR and direct DNA sequencing. RESULTS: All patients presented bilateral decrease in best-corrected visual acuity and temporal pallor of the optic disc. The visual fields of the adult patients showed characteristic scotomata. Other signs were present in some patients such as decreased color discrimination and a gray crescent within the neuroretinal rim. After the OPA1 gene was sequenced, a previously undescribed heterozygous splice-site mutation c.784–1G>T in intron 7 was detected in family F2. In families F1, F3, and F4, a previously reported in-frame deletion c.876_878delTGT/p.(Val294del), the frameshift c.2366delA/p.(Asn789Metfs*11), and splice-site c.1140+5G>C mutations were detected, respectively. CONCLUSIONS: This is the first report of molecular characterization of Greek patients with ADOA. Our findings provide additional information regarding the genotype-phenotype correlation and establish the role of the OPA1 gene in Greek patients with ADOA. Molecular Vision 2014-05-27 /pmc/articles/PMC4037535/ /pubmed/24883014 Text en Copyright © 2014 Molecular Vision. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited, used for non-commercial purposes, and is not altered or transformed.
spellingShingle Research Article
Kamakari, Smaragda
Koutsodontis, George
Tsilimbaris, Miltiadis
Fitsios, Athanasios
Chrousos, Georgia
First report of OPA1 screening in Greek patients with autosomal dominant optic atrophy and identification of a previously undescribed OPA1 mutation
title First report of OPA1 screening in Greek patients with autosomal dominant optic atrophy and identification of a previously undescribed OPA1 mutation
title_full First report of OPA1 screening in Greek patients with autosomal dominant optic atrophy and identification of a previously undescribed OPA1 mutation
title_fullStr First report of OPA1 screening in Greek patients with autosomal dominant optic atrophy and identification of a previously undescribed OPA1 mutation
title_full_unstemmed First report of OPA1 screening in Greek patients with autosomal dominant optic atrophy and identification of a previously undescribed OPA1 mutation
title_short First report of OPA1 screening in Greek patients with autosomal dominant optic atrophy and identification of a previously undescribed OPA1 mutation
title_sort first report of opa1 screening in greek patients with autosomal dominant optic atrophy and identification of a previously undescribed opa1 mutation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037535/
https://www.ncbi.nlm.nih.gov/pubmed/24883014
work_keys_str_mv AT kamakarismaragda firstreportofopa1screeningingreekpatientswithautosomaldominantopticatrophyandidentificationofapreviouslyundescribedopa1mutation
AT koutsodontisgeorge firstreportofopa1screeningingreekpatientswithautosomaldominantopticatrophyandidentificationofapreviouslyundescribedopa1mutation
AT tsilimbarismiltiadis firstreportofopa1screeningingreekpatientswithautosomaldominantopticatrophyandidentificationofapreviouslyundescribedopa1mutation
AT fitsiosathanasios firstreportofopa1screeningingreekpatientswithautosomaldominantopticatrophyandidentificationofapreviouslyundescribedopa1mutation
AT chrousosgeorgia firstreportofopa1screeningingreekpatientswithautosomaldominantopticatrophyandidentificationofapreviouslyundescribedopa1mutation